{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:28:16Z","timestamp":1760171296946,"version":"3.41.2"},"reference-count":10,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An 18-year-old girl was evaluated for primary amenorrhea. She was diagnosed with hemoglobin E (HbE)\/beta-thalassemia during childhood and needed blood transfusions every month to maintain adequate hemoglobin levels. She was started on thalidomide to reduce her transfusion requirements at 12 years of age and became transfusion independent after 6 months. She had normal stature and Tanner stage 4 sexual maturation, but she failed to attain menarche. Investigations revealed that she had elevated serum gonadotropin levels, indicating primary ovarian dysfunction. Her karyotype was 46,XX. Ultrasonographic examination demonstrated the absence of follicles in both ovaries. There was no evidence of abnormalities of the urogenital tract. Thalidomide was stopped, and she attained menarche spontaneously 3 months thereafter. Subsequently, her menstrual cycles were regular. Repeat ultrasound scans demonstrated the presence of ovarian follicles as well as an increase in ovarian volume. Mechanistic links between ovarian dysfunction and thalidomide remain to be found. One possibility is impaired blood flow and follicular development.<\/jats:p>","DOI":"10.1210\/jcemcr\/luad057","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:03:24Z","timestamp":1686197004000},"source":"Crossref","is-referenced-by-count":1,"title":["Thalidomide-Induced Primary Amenorrhea in a Patient With HbE\/Beta-Thalassemia"],"prefix":"10.1210","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-1376","authenticated-orcid":false,"given":"Arijit","family":"Singha","sequence":"first","affiliation":[{"name":"Department of Endocrinology & Metabolism, Institute of Postgraduate Medical Education & Research , Kolkata, West Bengal 700020 , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-9589","authenticated-orcid":false,"given":"Pradip","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Metabolism, Institute of Postgraduate Medical Education & Research , Kolkata, West Bengal 700020 , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5397-961X","authenticated-orcid":false,"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Metabolism, Institute of Postgraduate Medical Education & Research , Kolkata, West Bengal 700020 , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"6","key":"2023060804031879200_luad057-B1","first-page":"1429","article-title":"Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy","volume":"27","author":"Ordi-Ros","year":"2000","journal-title":"J Rheumatol"},{"issue":"12","key":"2023060804031879200_luad057-B2","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/1529-0131(199812)41:12<2273::AID-ART26>3.0.CO;2-6","article-title":"Thalidomide induces amenorrhea in patients with lupus disease","volume":"41","author":"Ordi","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2023060804031879200_luad057-B3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41392-021-00811-0","article-title":"Safety and efficacy of thalidomide in patients with transfusion-dependent \u03b2-thalassemia: a randomized clinical trial","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2023060804031879200_luad057-B4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.fertnstert.2003.12.038","article-title":"Thalidomide-induced amenorrhea: case report and literature review","volume":"82","author":"Dharia","year":"2004","journal-title":"Fertil Steril"},{"key":"2023060804031879200_luad057-B5","first-page":"42","article-title":"Hypogonadism in thalassemia major patients","volume":"5","author":"Srisukh","year":"2016","journal-title":"J Clin Transl Endocrinol"},{"issue":"4","key":"2023060804031879200_luad057-B6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/S0967199420000222","article-title":"Interleukin-1\u03b2 and TNF-\u03b1 systems in ovarian follicles and their roles during follicular development, oocyte maturation and ovulation","volume":"28","author":"Silva","year":"2020","journal-title":"Zygote"},{"issue":"5","key":"2023060804031879200_luad057-B7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/humupd\/dmu019","article-title":"Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents","volume":"20","author":"Roness","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2023060804031879200_luad057-B8","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.fertnstert.2011.07.134","article-title":"Thalidomide reduces ovarian microvasculature and protects ovarian follicles from chemotherapy damage","volume":"96","author":"Ochalski","year":"2011","journal-title":"Fertil Steril"},{"issue":"3","key":"2023060804031879200_luad057-B9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.medcli.2017.02.026","article-title":"Amenorrhea during thalidomide treatment: an unusual cause of ovarian failure? Amenorrea durante el tratamiento con talidomida: \u00bfuna causa infrecuente de disfunci\u00f3n ov\u00e1rica?","volume":"149","author":"Pulido-P\u00e9rez","year":"2017","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"2023060804031879200_luad057-B10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2008-1036884","article-title":"Gyn\u00e4kologisch-endokrinologische untersuchungen bei thalidomidgesch\u00e4digten M\u00e4dchen [gynecological and endocrinological studies of thalidomide-damaged girls]","volume":"44","author":"M\u00fchlenstedt","year":"1984","journal-title":"Geburtshilfe Frauenheilkd"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/1\/3\/luad057\/50536781\/luad057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/1\/3\/luad057\/50536781\/luad057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:03:30Z","timestamp":1686197010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luad057\/7191872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5,8]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luad057","relation":{},"ISSN":["2755-1520"],"issn-type":[{"type":"electronic","value":"2755-1520"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,5]]},"article-number":"luad057"}}